US FDA

21 CFR 211.34 - Consultants

Plain-language explanation, inspection context and common violation patterns.

What it says

Consultants advising on the manufacture, processing, packing or holding of drug products must have sufficient education, training and experience to advise on the subject for which they are retained, and records must be maintained stating the name, address, qualifications and type of service provided by each consultant.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

What FDA inspectors look for

Most common violation

Significant quality decisions, such as a root cause investigation or validation strategy, based substantially on a consultant's recommendation with no documented internal review or independent quality unit judgment applied to that recommendation.

Related regulations

Want a deeper, interactive breakdown?

GMPify's Regulation Explainer tool gives subscribers an AI-powered analysis of any 21 CFR, EU GMP, USP or ICH reference, with live inspection context.

Try the Regulation Explainer →